title: Threats to international travellers posed by tick-borne diseases.
abstract: To date, 14 tick-borne diseases have been reported in international travellers, the majority of cases being Lyme borreliosis caused by Borrelia burgdorferi sensu lato in North America and Eurasia, African tick bite fever caused by Rickettsia africae in sub-Saharan Africa and eastern Caribbean, and Central European encephalitis caused by tick-borne encephalitis virus in Europe. The clinical presentation is frequently non-specific, and tick-borne diseases should always, in the absence of other likely diagnoses, be suspected in travellers with flu-like symptoms following a recent visit to tick-infested areas. Feasible microbiological diagnostic tests are widely unavailable, at least outside areas of endemicity where many infected travellers present. Empiric treatment with doxycycline should be considered in suspected cases of tick-borne bacterial diseases. Since ecotourism and adventure travel are increasingly popular worldwide, the incidence of travel-associated tick-borne diseases is likely to increase in the future.
authors.affiliation: Department of Internal Medicine, Aker University Hospital, Oslo, Norway. mogens.jensenius@ioks.uio.no
authors.forename: Mogens
authors.initials: M
authors.lastname: Jensenius
authors.forename: Philippe
authors.initials: P
authors.lastname: Parola
authors.forename: Didier
authors.initials: D
authors.lastname: Raoult
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents; D004318:Doxycycline / Q000008:administration & dosage; D014943:Global Health; D006801:Humans; D017282:Tick-Borne Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D013987:Ticks / Q000469:parasitology / Q000821:virology; D014195:Travel
chemical_list: D000900:Anti-Bacterial Agents; D004318:Doxycycline